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Abstract 
 
Circadian clocks time the daily occurrence of multiple aspects of behaviour and 
physiology.  Through studies of chronic misalignment between our internal clocks 
and the environment (e.g. during shift work), it has long been postulated that 
disruption of circadian rhythms is detrimental to human health.  Recent advances in 
understanding of the cellular and molecular basis of mammalian circadian timing 
mechanisms have identified many key genes involved in circadian rhythm generation 
and demonstrated the presence of clocks throughout the body.  Furthermore, clear 
links between sleep, circadian rhythms and metabolic function have been revealed and 
much current research is studying these links in more detail.  Here, we review the 
current evidence linking circadian rhythms, clock genes and adipose biology.  We 
also highlight gaps in our understanding and finally suggest avenues for future 
research. 
 
 
Introduction 
 
Circadian rhythms are endogenously controlled changes in physiology and behaviour 
that enable organisms to regulate their biology in anticipation of predictable daily 
changes in the environment.  These rhythms occur with a periodicity of approximately 
24 hours and, in order to maintain an appropriate temporal relationship with the 
outside world, the phase of endogenous clocks is synchronised (entrained) by external 
time cues, termed zeitgebers (1). 
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In mammals, the master circadian clock resides within the suprachiasmatic nuclei 
(SCN) of the anterior hypothalamus (2,3).  For a number of years, it was believed that 
the SCN represented one of only a few tissues capable of generating circadian 
rhythms; indeed, the SCN clock was believed to ultimately drive most rhythmic 
physiological and behavioural rhythms.  However, circadian clocks have now been 
identified in nearly all tissues (4,5) and even in immortalised cell lines (6).  These 
findings have necessitated a change in the perception of the cellular organisation of 
the clock, which is now conceptualised as an integrated circadian timing system (7) 
(Figure 1).  In this complex system, clocks present in peripheral tissues drive local 
aspects of physiology.  These so-called peripheral clocks are synchronised by multiple 
output pathways from the SCN (8), which thus retains its position as the master clock 
but acts by co-ordinating daily rhythms throughout the body. 
 
The molecular basis of the mammalian circadian clock has been reviewed in detail 
elsewhere (1).  In brief, the clock is based on transcriptional-translational feedback 
loops.  In the central clock loop, the basic helix-loop-helix transcription factors 
BMAL1 and CLOCK (or its paralog NPAS2) stimulate transcription of three Period 
(Per1-3) and two Cryptochrome (Cry1-2) genes via E-box elements within their 
promoter regions.  The translated PER and CRY proteins then form the basis of 
inhibitory complexes that translocate back into the nucleus and bind to CLOCK-
BMAL1 proteins to inhibit their activity and thus the transcription of the Per and Cry 
genes.  Within this cyclical process, the stability of PER and CRY proteins is tightly 
controlled by casein kinases (CK1δ/ε) and the F-box protein FBXL3, respectively (9-
15).  Such post-translational control is believed to be critical in determining the length 
of the molecular oscillations (16). 
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 Secondary feedback loops also exist within the circadian mechanism.  The best 
characterised of these drives rhythmical expression of Bmal1 via retinoic acid-related 
orphan receptor response elements (ROREs) present within its promoter (17). In this 
loop, CLOCK-BMAL1 dimers stimulate the rhythmic transcription of Rev-erbα, 
which represses Bmal1 transcription following translation into REV-ERBα protein.  
The purpose of these secondary loops is unclear but may provide additional 
robustness to the primary loop or perhaps provide mechanisms through which 
external processes (e.g. metabolic state) may interact with circadian biology. 
 
In order for the molecular clock mechanism described above to regulate cellular 
physiology, it must be able to communicate temporal information to other 
intracellular pathways.  It is now recognised that core clock proteins not only regulate 
the expression of other clock genes but also of output (or ‘clock-controlled’) genes by 
binding to circadian promoter elements, including E-boxes and ROREs (18-20).  
Many of these clock-controlled genes are themselves transcription factors that then 
regulate the expression of further downstream target genes; for example, the D-
element binding protein gene (Dbp) is rhythmically expressed via E-boxes in its 
promoter and the resulting circadian profile of DBP protein then rhythmically induces 
transcription of downstream genes via activation of D-boxes.  Through such 
mechanisms, the circadian clock is believed to drive rhythmical expression of 
approximately 10% of the transcriptome of most tissues (21). 
 
Following from these advances in our knowledge of basic circadian mechanisms, 
importance is now being attached to understanding how the circadian timing system 
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interacts with other physiological systems.  Indeed, one of the key challenges of the 
field is to determine the functional role of circadian timing processes in health and 
disease. 
 
 
Linking the clock to adipose function 
 
There are multiple lines of evidence that suggest a close relationship between 
circadian rhythms and adipose biology.  Indeed, multiple aspects of adipose-related 
physiology display daily variation.  For instance, in humans 24-hour rhythms have 
been reported in the circulating blood-borne concentration of leptin and adiponectin 
(22,23), which are members of the fat-derived hormone family, the adipokines (24).  
Most of these studies have been performed with the experimental subjects being kept 
in fluctuating external conditions, including a light-dark cycle.  As a result, the 
reported rhythms are not necessarily circadian in nature, as they may be in part driven 
by the presence of rhythmic zeitgebers.  However, the importance of endogenous 
circadian mechanisms in driving circadian adipokine secretion has been demonstrated 
in rodent models, in which leptin and adiponectin secretion is dependent on a 
functional SCN and persists in constant darkness (25,26).  Whether human adipokine 
rhythms persist in the absence of environmental cues remains to be determined. 
 
Further links between circadian and adipose physiology lie at the molecular level, in 
cellular, animal and human models.  There is now in vitro evidence to suggest that 
multiple clock genes play a role in adipocyte differentiation.  Not only does the 
expression of both Rev-erbα and Bmal1 mRNA increase approximately 3-4 days 
 5
following the onset of differentiation of cultured adipocytes (27-28), but manipulation 
of gene expression in cultured cells indicates that they both promote the 
differentiation process (28-29).  However, their expression is apparently not necessary 
for adipocyte differentiation in vivo as juvenile Bmal -/- mice and adult Rev-erbα-/- 
mice do not exhibit any gross adipose abnormalities compared to their respective wild 
type controls (30-31). 
 
Despite the lack of gross adipose abnormalities in juvenile Bmal-/- mice and adult Rev-
erbα-/- mice, many mutant mouse lines bearing genetic lesions of clock or clock-
related genes exhibit abnormal lipid processing.  Mice expressing the dominant 
negative allele ClockΔ19 on a C57BL/6J background display many of the symptoms 
of metabolic syndrome, including adipocyte hypertrophy, hyperleptinemia, 
hyperlipidemia, hepatic steatosis, hyperglycemia and hypoinsulinemia (32).  In 
addition, serum VLDL triglycerides and apolipoprotein C-III concentration are 
elevated in Rev-erbα-/- mice (33), and mice with targeted disruption of the Nocturnin 
gene, which encodes a clock-controlled deadenylase, are resistant to diet-induced 
obesity (34).  Adult Bmal1-/- mice exhibit a reduction of fat and other tissues, although 
this may be due to premature ageing, rather than a specific abnormality of adipose 
physiology per se (31). 
 
One caveat when considering the metabolic phenotype of genetically altered mice is 
the effect of genetic background on expression of the phenotype.  As has been 
reported in other models (35), the background genotype of mice appears to influence 
the expressed metabolic phenotype of the ClockΔ19 mutation onto other mouse lines 
(36-37).  After crossing the ClockΔ19 mutation onto an ICR background, Oishi et al 
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reported a reduction in dietary fat absorption and subsequent protection against 
obesity induced by a high fat diet.  Kennaway et al crossed the ClockΔ19 mutation 
onto a melatonin-proficient CBA line and reported a metabolic phenotype including 
elevated plasma adiponectin and reduced plasma free fatty acid concentration.  
However, despite these phenotypic differences, a common thread through the studies 
described above is that disruption of clock and clock-related genes induces metabolic 
disruption and lipid homeostasis. 
 
Building on the rodent studies, a number of groups have now reported associations 
between metabolic disruption and polymorphisms of human clock genes.  Variants of 
BMAL1, NPAS2 and PER2 have been linked to components of metabolic syndrome, 
including hypertension and glucose dysregulation (38-39).  Moreover, studies of both 
British (40) and Argentinean (41) populations have investigated polymorphisms of the 
CLOCK gene and found significant relationships between CLOCK haplotypes and the 
presence of obesity and metabolic syndrome.  These data therefore complement the 
animal studies and are consistent with an interaction between clock genes and lipid 
metabolism.  
 
Finally, consistent with the existence of a localised peripheral clock within WAT, 
rhythmical clock gene expression has been reported in adipose tissue.  These studies 
are discussed in detail below.  
 
 
Adipose tissue rhythms 
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Rhythms in adipose tissue and the effect of diet 
 
Analysis of murine adipose gene expression has revealed 24-hour rhythms of 
adipokine clock gene expression.  The relative phasing of gene expression in WAT is 
consistent with SCN rhythms and the molecular model of the circadian clock 
suggesting the presence of a circadian clock within WAT (42-43).  Moreover, use of 
microarrays suggests that up to 20% of the murine adipose transcriptome is expressed 
according to a diurnal rhythm, with many of the identified genes being involved in 
metabolism (43-44).  Similar data have also been reported with human WAT arrays, 
albeit with a limited number of diurnal sampling time points (45).  It therefore appears 
that many aspects of mammalian adipose biology are regulated on a 24 hour basis. 
 
Interestingly, WAT tissue rhythms are altered in obese individuals and are sensitive to 
diet.  Ando et al compared rhythms of clock gene expression in WAT taken from 
three mouse lines; one was lean, another was obese with mild type 2 diabetes mellitus 
(T2DM) and a third was obese with sever T2DM.  The data revealed markedly 
reduced rhythm amplitude in obese mouse lines, compared to lean mice (42).  This 
finding has notable similarities with previous reports of reduced amplitude rhythms of 
plasma adipokines in obese human subjects (22,46-48), suggesting that rhythms of 
both gene expression and endocrine activity may be attenuated in WAT of obese 
individuals.   The role of diet on adipose rhythms has been investigated using 
different experimental paradigms.  Administration of a high fat diet to mice for 6 
weeks had multiple effects on circadian physiology, including a lengthening of the 
period of behavioural rhythms and also altered diurnal gene expression rhythms in 
both WAT and liver (49).  Consistent with data relating to other peripheral tissues, 
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restriction of food availability to the light phase regulates the phase of adipose 
rhythms in mice (43).  Finally, in overweight human subjects, short-term fasting also 
alters diurnal human sub-cutaneous WAT rhythms (45).  Together, these data not only 
indicate a key role of daily rhythms in adipose function, but that there is a functional 
relationship between metabolic state and the phasing and/or robustness of adipose 
rhythms. 
 
Despite their importance in identifying molecular rhythms in adipose tissue, there are 
some limitations with the above studies.  As with the reports of adipokine rhythms in 
human plasma, they were conducted in changing light-dark cycle and so the 
contribution of endogenous timing mechanisms cannot be readily distinguished from 
possible masking effects of environmental rhythms.  Also, the complex composition 
of adipose tissue and its input pathways makes the cellular basis of adipose rhythms 
unclear.  These factors are discussed in detail below. 
 
 
WAT cellular heterogeneity 
 
As with other tissues, WAT is comprised of multiple different cell types and this 
heterogeneity causes difficulty interpreting which cells contribute to rhythmicity at 
the tissue level.  In addition to adipocytes and pre-adipocytes, WAT contains a wide 
variety of cells that are believed to contain endogenous clocks (Table 1). 
 
Other potential confounding factors when interpreting rhythmicity in WAT are 1) the 
inflammatory state of the tissue and 2) the origin of the WAT explant.  One aspect of 
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obesity is the chronic inflammatory state of adipose tissue (50).  During this time, the 
balance of the WAT cellular composition changes, notably including an increase in 
the macrophage content of the tissue.  It is now clearly understood that different 
adipose depots have markedly different influences over body metabolism; for 
example, visceral WAT is a much better predictor of metabolic syndrome than 
subcutaneous fat (51).  This differential function of adipose depots also appears to 
extend to circadian rhythmicity, as the phase of clock gene rhythms in adipose tissue 
is dependent upon anatomical location (52-53). 
 
 
Rhythmical inputs 
 
As with other peripheral tissues, WAT is subject to a variety of rhythmical input 
signals (Figure 2).  Many of these inputs are neuroendocrine in origin; neuronal inputs 
include autonomic innervation; endocrine inputs include melatonin and 
glucocorticoids.  Other putative rhythmical inputs include feeding and paracrine 
factors from other WAT cells, e.g. macrophage cytokines.  Although the likelihood of 
physiological redundancy makes it difficult to identify the role of individual 
signalling pathways in the synchronisation of WAT rhythms in vivo, there is evidence 
that these neuroendocrine and behavioural rhythms are involved in the entrainment of 
at least some peripheral clocks. 
 
Feeding behaviour 
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It has been recognised for a number of years that temporal restriction of food 
availability acts as a powerful environmental time cue that regulates circadian 
rhythms (54).  In nocturnal rodents, restriction of food availability to the day time 
synchronises rhythms of food anticipatory activity and gene expression in peripheral 
tissues, including WAT (43).  In most experimental models, the SCN remain 
entrained to the light-dark cycle, resulting in an uncoupling with many peripheral 
tissues.  However, in some mouse strains and during both temporal and caloric food 
restriction, SCN rhythms also entrain to food availability (55-57). 
 
The mechanisms through which temporal food availability regulate circadian clocks 
are poorly understood.  Changes in metabolite concentration are able to synchronise 
cultured cells in vitro (58) and so may also contribute to synchronisation in vivo.  
Furthermore, there is a wealth of evidence supporting the existence of a food-
entrainable oscillator (FEO), which lies outside of the SCN and is capable of driving 
physiological and behavioural rhythms (54).  Although the location(s) of the FEO is 
the subject of much current debate (59,60), its role within the circadian timing system 
is likely to be of great physiological importance. 
 
Autonomic innervation 
 
The autonomic nervous system is a major physiological regulator of many peripheral 
tissues.  Neuronal outputs from the SCN directly regulate the activity of hypothalamic 
pre-autonomic neurones, and thus the activity of the autonomic nervous system 
exhibits circadian changes (61).  In particular, sympathetic innervation has a key role 
in driving many peripheral rhythms, including pineal melatonin synthesis, hepatic 
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glucose metabolism and adrenal corticosteroid secretion.   Interestingly, denervation 
of the sympathetic input to the submaxillary glands made these tissues more receptive 
to the synchronising effects of temporal food availability (62), indicating that a 
complex interaction between different physiological entraining stimuli may exist for 
peripheral clocks. 
 
There is some controversy in the literature regarding the parasympathetic control of 
WAT (63,64).  However, clear evidence for sympathetic innervation of WAT function 
has been available for many years (65).  This sympathetic innervation exerts 
physiological control over WAT, for example increasing lipolysis, and may 
conceivably also entrain circadian rhythms in this tissue. 
 
Melatonin 
 
Melatonin is the primary product of the pineal gland and exhibits an extremely robust 
daily rhythm of secretion, with elevated plasma melatonin concentration at night (66).  
In many model systems, melatonin has proven to be a powerful entraining signal for 
circadian rhythms.  At the molecular level, much of our understanding of melatonin 
signalling on circadian rhythms comes from studies of the pars tuberalis of the 
anterior pituitary.  In this tissue, melatonin signals through its MT1 receptor subtype 
to regulate the expression of multiple clock genes (67-69).  Furthermore, recent array 
studies have demonstrated that melatonin is likely to have acute stimulatory and 
inhibitory effects on a wide range of signalling pathways (70,71). 
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Pinealectomy modifies sensitivity of rats to insulin, suggesting a role for melatonin in 
energy balance in vivo (72).  Studies of cultured cells indicate that melatonin 
receptors are expressed on adipocytes (73,74) and that melatonin may directly 
regulate lipolysis and leptin expression (74,75).  However, the ability of melatonin to 
regulate adipose rhythms is currently unknown. 
 
Glucocorticoids 
 
The secretion of glucocorticoids from the adrenal cortex also exhibits a clear circadian 
rhythm, controlled by a combination of 1) SCN regulation of the hypothalamo-
pituitary-adrenal axis, 2) SCN regulation of autonomic input to the adrenal gland and 
3) rhythmic sensitivity to ACTH driven by a local adrenal clock (76).  Administration 
of the glucocorticoid receptor agonist dexamethasone entrains liver clock gene 
rhythms in vivo (77) and can synchronise cultured cells, including fibroblasts and 
adipocytes, in vitro (78,79).  Interestingly, although physiological glucocorticoid 
signalling does not appear to regulate liver expression of core clock genes, rhythmic 
expression of a large proportion of cycling liver genes appears to be dependent upon a 
functional adrenal gland (80).  Moreover, liver-specific loss of glucocorticoid 
signalling accelerates the entrainment of mice to a temporally restricted feeding 
paradigm (81).  Thus, there is evidence that both exogenous and endogenous 
glucocorticoid hormones are capable of regulating peripheral clock function. 
 
 
Adipocyte rhythmicity in vitro 
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A recent study has investigated rhythmic gene expression in explants of human WAT.  
Here, visceral and subcutaneous adipose tissue was removed from obese subjects, 
kept in tissue culture conditions overnight and then analysed every 6 hours over a 24 
hour period (53).  Rhythmic expression was observed for selected clock genes and 
also other adipose-related genes, consistent with the hypothesis that WAT contains its 
own autonomous clock.  However, it is still unclear from this study whether the clock 
lies in the adipocytes, or some other cell type(s).  In order to address this question, 
some groups have begun to study cultures of adipose-derived cells. 
 
The ability to use cultured cells to analyse circadian rhythms was first demonstrated 
using hepatic fibroblast cultures (6).  Application of a ‘pulse’ of high serum 
concentration or one of many pharmacological stimuli has been shown to induce 
molecular rhythms within a cell population using many different cell types, including 
immortalised cell lines (78).  Elegant analysis of single cell fibroblast rhythms using 
reporter constructs shows that the effect of the pulse is not to induce rhythmicity 
within cells, but rather to synchronise existing cellular rhythms that have drifted out 
of phase with one another (82,83). 
 
The first study to apply the pulse technique to adipose physiology utilised human 
subcutaneous adipose-derived stem cells (ASCs).  Following a 2-hour pulse with 
either dexamethasone, rosiglitazone or 30% foetal bovine serum, circadian expression 
of selected clock genes was observed in both undifferentiated and adipocyte-
differentiated ASCs (79).  Similarly, a later study reported rhythms of Per1 and 
Bmal1 mRNA in undifferentiated ASCs following a 1-hour pulse with 50% foetal 
bovine serum (84). 
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 We have taken a similar approach to investigate murine adipocyte rhythms and have 
studied the well-characterised 3T3-L1 cell model (Otway, Frost, Johnston 
unpublished observations).  Although these cells are known to express clock genes 
(28,85), there are no available quantitative data describing temporal changes in their 
physiology.  Our data are consistent with some of the ASC findings described above, 
but also add extra levels of analysis and reveal some interesting differences.  
Consistent with the ASC data (79,84), we observed rhythmical variation of Per2, Dbp 
and Rev-erbα expression in pre-adipocytes.  However, we failed to observe circadian 
rhythmicity of other genes involved in the circadian clock (Per1, Cry1, Bmal1) or 
other aspects of adipocyte biology (PPARα, PPARγ, SREBP1).  This result was 
surprising given that all of the genes are rhythmic in murine WAT (42-44,86) and 
therefore suggest that some of the reported rhythmicity in murine WAT may derive 
from non-adipocyte cell types and/or rhythmical input signal(s). 
 
In differentiated 3T3-L1 adipocytes, we found that expression of Per2, Dbp and Rev-
erbα were again rhythmic, but the other genes tested exhibited no obvious circadian 
pattern.  Although the rhythmic expression of Rev-erbα was similar to that in the pre-
adipocytes, the amplitude of Per2 and Dbp rhythms was markedly attenuated.  The 
reason for this could potentially be due to attenuated intra-cellular rhythm amplitude 
or a decreased ability of the serum pulse to synchronise the cell population.  Finally, 
in contrast to a lack of circadian Leptin and Adiponectin mRNA expression, our data 
indicate that adipocyte clocks may drive circadian secretion of leptin, but not 
adiponectin.  Although the mechanism of circadian leptin secretion is currently 
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unclear, this is the first indication of an adipocyte-based mechanism driving the 
plasma leptin rhythms described above. 
 
 
Conclusion 
 
There is an increasing body of evidence linking circadian rhythms and clock genes 
with adipose physiology and pathophysiology.  Despite the progress made in 
understanding adipose rhythms over the past few years, there are a number of 
important research avenues that remain to be explored.  Of particular importance will 
be an understanding of rhythmic input pathways and intercellular communication, the 
relationship between circadian and metabolic dysfunction, and the generation of cell- 
and tissue-specific clock knockout models.  Given the importance of obesity and 
metabolic disease in contemporary society, a clearer understanding of the function of 
adipose clocks has great potential therapeutic value. 
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Figure Legends 
 
Figure 1.  Modelling the mammalian circadian timing system.  (A) The master 
circadian clock in the hypothalamic suprachiasmatic nuclei (SCN) was previously 
thought to directly drive rhythms throughout the body.  (B) It is now recognised that 
autonomous clocks are present in most tissues.  The role of the SCN is now 
considered to be synchronisation of these peripheral clocks to ensure that they 
oscillate in an appropriate phase to each other.  This synchronisation occurs through 
multiple neuroendocrine pathways and temporal regulation of behaviour, such as 
feeding. 
 
Figure 2.  Complexity of adipose rhythms.  Interpretation of the underlying 
mechanisms of adipose tissue rhythms is complicated by both the multiple rhythmic 
input pathways and also the heterogeneous nature of adipose cells. 
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Table 1: Presence of circadian clocks in adipose tissue cell types 
 
Interpretation of adipose rhythms is complicated by the identification of circadian 
clocks in multiple cell types found in adipose tissue. 
 
 
Cell type Presence of a circadian 
clock 
References 
Pre-adipocyte Yes 79,84 
Adipocyte Yes 79 
Fibroblast Yes 6,82,83 
Macrophage Yes 87 
Vascular 
endothelial cell 
Yes 88 
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